STOCK TITAN

[8-K] AMARIN CORP PLC\UK Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Amarin Corporation plc furnished a Form 8-K announcing it issued a press release with financial results for the three and nine months ended September 30, 2025 and 2024.

The press release is included as Exhibit 99.1. The information is furnished under Item 2.02 and is not deemed filed under Section 18 of the Exchange Act, except as specifically incorporated by reference in future filings.

Amarin Corporation plc ha presentato un modulo 8-K annunciando di aver emesso un comunicato stampa con i risultati finanziari per i tre e nove mesi terminati il 30 settembre 2025 e 2024.

Il comunicato stampa è incluso come Exhibit 99.1. Le informazioni sono fornite ai sensi della voce 2.02 e non si ritengono depositate ai sensi della Sezione 18 del Securities Exchange Act, salvo quanto specificamente incorporato per riferimento nei futuri depositi.

Amarin Corporation plc presentó un Form 8-K anunciando que emitió un comunicado de prensa con los resultados financieros para los tres y nueve meses finalizados al 30 de septiembre de 2025 y 2024.

El comunicado de prensa se incluye como Exhibit 99.1. La información se proporciona conforme a la Item 2.02 y no se considera presentada conforme a la Sección 18 de la Exchange Act, salvo que se incorpore específicamente por referencia en presentaciones futuras.

Amarin Corporation plc는 2025년 9월 30일 및 2024년 9월 30일에 종료된 3개월 및 9개월의 재무 실적에 관한 보도자료를 발표했다는 Form 8-K를 제출했습니다.

보도자료는 Exhibit 99.1로 포함되어 있습니다. 이 정보는 Item 2.02에 따라 제공되며, 향후 제출 문서에서 명시적으로 참조에 포함되지 않는 한 Exchange Act의 섹션 18에 따라 제출된 것으로 간주되지 않습니다.

Amarin Corporation plc a déposé un Form 8-K annonçant qu'il a publié un communiqué de presse présentant les résultats financiers pour les trois et neuf mois terminés le 30 septembre 2025 et 2024.

Le communiqué de presse est inclus en tant qu'Exhibit 99.1. L'information est fournie en vertu de l'Item 2.02 et n'est pas réputée déposée en vertu de la Section 18 du Exchange Act, sauf si elle est expressément incorporée par référence dans les dépôts futurs.

Amarin Corporation plc hat ein Form 8-K vorgelegt und mitgeteilt, dass es eine Pressemitteilung mit den Finanzergebnissen für die drei- und neunmonatigen Zeiträume zum 30. September 2025 und 2024 veröffentlicht hat.

Die Pressemitteilung ist als Exhibit 99.1 enthalten. Die Informationen werden gemäß Item 2.02 bereitgestellt und gelten nicht als unter Abschnitt 18 des Exchange Act eingereicht, außer soweit sie ausdrücklich durch Bezugnahme in zukünftigen Einreichungen aufgenommen werden.

Amarin Corporation plc قدمت نموذج 8-K معلنة أنها أصدرت بياناً صحافياً يحتوي على نتائج مالية للأشهر الثلاثة والتسعة المنتهية في 30 سبتمبر 2025 و2024.

يُدرج البيان الصحفي كمعروض Exhibit 99.1. تُقدَّم المعلومات وفقًا للبند Item 2.02 ولا تُعتبر مُودعة بموجب القسم 18 من قانون التداول، باستثناء ما يتم دمجه صراحة بالرجوع إليه في التسجيلات المستقبلية.

Positive
  • None.
Negative
  • None.

Amarin Corporation plc ha presentato un modulo 8-K annunciando di aver emesso un comunicato stampa con i risultati finanziari per i tre e nove mesi terminati il 30 settembre 2025 e 2024.

Il comunicato stampa è incluso come Exhibit 99.1. Le informazioni sono fornite ai sensi della voce 2.02 e non si ritengono depositate ai sensi della Sezione 18 del Securities Exchange Act, salvo quanto specificamente incorporato per riferimento nei futuri depositi.

Amarin Corporation plc presentó un Form 8-K anunciando que emitió un comunicado de prensa con los resultados financieros para los tres y nueve meses finalizados al 30 de septiembre de 2025 y 2024.

El comunicado de prensa se incluye como Exhibit 99.1. La información se proporciona conforme a la Item 2.02 y no se considera presentada conforme a la Sección 18 de la Exchange Act, salvo que se incorpore específicamente por referencia en presentaciones futuras.

Amarin Corporation plc는 2025년 9월 30일 및 2024년 9월 30일에 종료된 3개월 및 9개월의 재무 실적에 관한 보도자료를 발표했다는 Form 8-K를 제출했습니다.

보도자료는 Exhibit 99.1로 포함되어 있습니다. 이 정보는 Item 2.02에 따라 제공되며, 향후 제출 문서에서 명시적으로 참조에 포함되지 않는 한 Exchange Act의 섹션 18에 따라 제출된 것으로 간주되지 않습니다.

Amarin Corporation plc a déposé un Form 8-K annonçant qu'il a publié un communiqué de presse présentant les résultats financiers pour les trois et neuf mois terminés le 30 septembre 2025 et 2024.

Le communiqué de presse est inclus en tant qu'Exhibit 99.1. L'information est fournie en vertu de l'Item 2.02 et n'est pas réputée déposée en vertu de la Section 18 du Exchange Act, sauf si elle est expressément incorporée par référence dans les dépôts futurs.

Amarin Corporation plc hat ein Form 8-K vorgelegt und mitgeteilt, dass es eine Pressemitteilung mit den Finanzergebnissen für die drei- und neunmonatigen Zeiträume zum 30. September 2025 und 2024 veröffentlicht hat.

Die Pressemitteilung ist als Exhibit 99.1 enthalten. Die Informationen werden gemäß Item 2.02 bereitgestellt und gelten nicht als unter Abschnitt 18 des Exchange Act eingereicht, außer soweit sie ausdrücklich durch Bezugnahme in zukünftigen Einreichungen aufgenommen werden.

Amarin Corporation plc قدمت نموذج 8-K معلنة أنها أصدرت بياناً صحافياً يحتوي على نتائج مالية للأشهر الثلاثة والتسعة المنتهية في 30 سبتمبر 2025 و2024.

يُدرج البيان الصحفي كمعروض Exhibit 99.1. تُقدَّم المعلومات وفقًا للبند Item 2.02 ولا تُعتبر مُودعة بموجب القسم 18 من قانون التداول، باستثناء ما يتم دمجه صراحة بالرجوع إليه في التسجيلات المستقبلية.

Amarin Corporation plc 已提交 Form 8-K,宣布它发布了一份新闻稿,披露截至2025年9月30日和2024年9月30日的三个月及九个月的财务业绩。

该新闻稿作为 Exhibit 99.1 包含在内。信息是按 Item 2.02 提供的,除非在未来的提交中被明确引用,否则不被视为根据《证券交易法》第18条提交。

false0000897448AMARIN CORP PLC\UK00-000000000008974482025-10-292025-10-29

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 29, 2025

Amarin Corporation plc

(Exact name of registrant as specified in its charter)

 

 

 

England and Wales

0-21392

Not applicable

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

 

 

 

 

 

8th Floor, One Central Plaza, Dame Street,

Dublin 2, Co. Dublin, D02 K7K5, Ireland

Not applicable

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: +353 1 6699 020

 

Not Applicable

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol

Name of each exchange on which registered

American Depositary Shares (ADS(s)), each ADS representing the right to receive twenty (20) Ordinary Shares of Amarin Corporation plc

AMRN

Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.02. Results of Operations and Financial Condition.

On October 29, 2025, Amarin Corporation plc (“Amarin”) issued a press release announcing its financial results for the three and nine months ended September 30, 2025 and 2024 (the “Press Release”). A copy of the Press Release is furnished herewith as Exhibit 99.1.

The information in this report furnished pursuant to Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), if such subsequent filing specifically references the information furnished pursuant to Item 2.02 of this report.

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.

 

Description

99.1

 

Press Release (results of operations), dated October 29, 2025 (furnished herewith)

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

* * *


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Date: October 29, 2025

Amarin Corporation plc

 

 

 

 

By:

/s/ Aaron Berg

Aaron Berg

President and Chief Executive Officer


FAQ

What did Amarin (AMRN) disclose in this Form 8-K?

Amarin furnished a press release announcing financial results for the three and nine months ended September 30, 2025 and 2024.

Which exhibit contains Amarin’s results press release?

Exhibit 99.1 contains the results of operations press release dated October 29, 2025.

Is the information in this 8-K considered filed or furnished?

It is furnished under Item 2.02 and is not deemed filed under Section 18 of the Exchange Act unless specifically incorporated by reference.

What periods are covered by the results announced by Amarin (AMRN)?

The results cover the three and nine months ended September 30, 2025 and 2024.

What is Amarin’s trading symbol and listing?

Amarin trades on Nasdaq under the symbol AMRN as American Depositary Shares (each ADS represents twenty ordinary shares).

When was the press release dated?

The press release was dated October 29, 2025.
Amarin

NASDAQ:AMRN

AMRN Rankings

AMRN Latest News

AMRN Latest SEC Filings

AMRN Stock Data

391.73M
20.49M
1.88%
18.04%
2.06%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2